Data from a post-hoc analysis of the Phase 3 clinical trial of Stelara® (ustekinumab) for treatment of people with moderate-to-severe lupus further validates the value of the Lupus Foundation of ...

Assessing disease activity is an important part of daily practice, clinical trials and other lupus – related research. There are several tools that have been developed, but none is perfect. Each has ...

A decade ago, a group of scientists had the literally brilliant idea to use bioluminescent light to visualize brain activity. We started thinking: 'What if we could light up the brain from the inside?

Objective The ‘single-item measure’ was developed as a short self-report tool for assessing physical activity. The aim of this study was to test the criterion validity of the single-item measure ...